Antiviral Activity of Fermented Ginseng Extracts Against a Broad Range of Influenza Viruses

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2018 Sep 12

PMID 30200514

Citations 23

Authors

Ye Wang

Yu-Jin Jung

Ki-Hye Kim

Youngman Kwon

Yu-Jin Kim

Zhan Zhang

Heun-Soo Kang

Bao-Zhong Wang

Fu-Shi Quan

Sang-Moo Kang

Affiliations

Soon will be listed here.

Abstract

Ginseng products used as herb nutritional supplements are orally consumed and fermented to ginsenoside compounds by the intestinal microbes. In this study, we investigated antiviral protective effects of fermented ginseng extracts against different strains of influenza viruses in genetically diverse mouse models. Intranasal coinoculation of mice with fermented ginseng extract and influenza virus improved survival rates and conferred protection against H1N1, H3N2, H5N1, and H7N9 strains, with the efficacy dependent on the dose of ginseng samples. Antiviral protection by fermented ginseng extract was observed in different genetic backgrounds of mice and in the deficient conditions of key adaptive immune components (CD4, CD8, B cell, MHCII). The mice that survived primary virus inoculation with fermented ginseng extract developed immunity against the secondary infection with homologous and heterosubtypic viruses. In vitro cell culture experiments showed moderate virus neutralizing activity by fermented ginseng extract, probably by inhibiting hemagglutination and neuraminidase activity. This study suggests that fermented ginseng extracts might provide a means to treat influenza disease regardless of virus strains.

Citing Articles

Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng.

Huo C, Baek J, Kim K J Ginseng Res. 2025; 49(2):105-117.

PMID: 40061485 PMC: 11889387. DOI: 10.1016/j.jgr.2024.12.004.

In Vitro Investigations into the Potential Drug Interactions of Pseudoginsenoside DQ Mediated by Cytochrome P450 and Human Drug Transporters.

Li Z, Wang C, Liu J, Li P, Feng H Molecules. 2024; 29(11).

PMID: 38893358 PMC: 11173382. DOI: 10.3390/molecules29112482.

Antiviral activities of ginseng and its potential and putative benefits against monkeypox virus: A mini review.

Das R, Ratan Z, Rahman M, Runa N, Mondal S, Konstantinov K J Ginseng Res. 2023; .

PMID: 37362081 PMC: 10065872. DOI: 10.1016/j.jgr.2023.03.002.

Antiviral Potential of the Genus : An updated review on their effects and underlying mechanism of action.

Zhang Y, Zhong X, Xi Z, Li Y, Xu H J Ginseng Res. 2023; 47(2):183-192.

PMID: 36926608 PMC: 10014226. DOI: 10.1016/j.jgr.2022.11.003.

Antiviral Effect of Ginsenosides rk1 against Influenza a Virus Infection by Targeting the Hemagglutinin 1-Mediated Virus Attachment.

Yang X, Sun H, Zhang Z, Ou W, Xu F, Luo L Int J Mol Sci. 2023; 24(5).

PMID: 36902398 PMC: 10003360. DOI: 10.3390/ijms24054967.

References

Lee J, Lee Y, Lee Y, Hwang H, Kim K, Ko E . Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication. Nutrients. 2015; 7(2):1021-36. PMC: 4344572. DOI: 10.3390/nu7021021. View

Drake J . Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A. 1993; 90(9):4171-5. PMC: 46468. DOI: 10.1073/pnas.90.9.4171. View

Nguyen H, Zemlin M, Ivanov I, Andrasi J, Zemlin C, Vu H . Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol. 2007; 81(17):9331-8. PMC: 1951409. DOI: 10.1128/JVI.00751-07. View

Lee Y, Kim M, Lee Y, Hwang H, Lee J, Kim C . Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins. PLoS One. 2015; 10(9):e0137822. PMC: 4569442. DOI: 10.1371/journal.pone.0137822. View

Nguyen H, van Ginkel FW , Vu H, McGhee J, Mestecky J . Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes. J Infect Dis. 2001; 183(3):368-76. DOI: 10.1086/318084. View

Eom S, Hwang J, Jung J, Jee H, Kim K, Paik H . Short communication: Antioxidative and antibacterial activities on Staphylococcus aureus and Escherichia coli O157:H4 in milk with added ginseng marc extract fermented by Lactobacillus plantarum KCCM 11613P. J Dairy Sci. 2017; 100(10):7788-7792. DOI: 10.3168/jds.2017-12725. View

Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M . New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013; 9(10):e1003657. PMC: 3794996. DOI: 10.1371/journal.ppat.1003657. View

Lee J, Hwang H, Ko E, Lee Y, Kwon Y, Kim M . Immunomodulatory activity of red ginseng against influenza A virus infection. Nutrients. 2014; 6(2):517-29. PMC: 3942714. DOI: 10.3390/nu6020517. View

Wohlbold T, Nachbagauer R, Xu H, Tan G, Hirsh A, Brokstad K . Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. mBio. 2015; 6(2):e02556. PMC: 4453582. DOI: 10.1128/mBio.02556-14. View

10.

Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y . Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol. 2007; 178(4):2448-57. DOI: 10.4049/jimmunol.178.4.2448. View

11.

Doyle T, Hashem A, Li C, Van Domselaar G, Larocque L, Wang J . Universal anti-neuraminidase antibody inhibiting all influenza A subtypes. Antiviral Res. 2013; 100(2):567-74. DOI: 10.1016/j.antiviral.2013.09.018. View

12.

Doyle T, Li C, Bucher D, Hashem A, Van Domselaar G, Wang J . A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains. Biochem Biophys Res Commun. 2013; 441(1):226-9. DOI: 10.1016/j.bbrc.2013.10.041. View

13.

Lee J, Cho M, Hwang H, Ko E, Lee Y, Kwon Y . Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses. J Interferon Cytokine Res. 2014; 34(11):902-14. PMC: 4217040. DOI: 10.1089/jir.2013.0093. View

14.

Dai M, Wu H, Li H, Chen J, Chen J, Hu S . Effects and mechanisms of Geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2014; 20(1):46-53. DOI: 10.1016/j.intimp.2014.02.021. View

15.

Jung Y, Lee Y, Ngo V, Cho Y, Ko E, Hong S . Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection. Sci Rep. 2017; 7(1):17360. PMC: 5727132. DOI: 10.1038/s41598-017-17487-8. View

16.

. Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010; 59(33):1057-62. View

17.

Doyle T, Jaentschke B, Van Domselaar G, Hashem A, Farnsworth A, Forbes N . The universal epitope of influenza A viral neuraminidase fundamentally contributes to enzyme activity and viral replication. J Biol Chem. 2013; 288(25):18283-9. PMC: 3689970. DOI: 10.1074/jbc.M113.468884. View

18.

Pleschka S, Stein M, Schoop R, Hudson J . Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009; 6:197. PMC: 2785784. DOI: 10.1186/1743-422X-6-197. View

19.

Jang S, Park J, Kim S, Choi K, Ko E, Cha J . Red ginseng powder fermented with probiotics exerts antidiabetic effects in the streptozotocin-induced mouse diabetes model. Pharm Biol. 2016; 55(1):317-323. PMC: 6130625. DOI: 10.1080/13880209.2016.1237978. View

20.

Guo H, Santiago F, Lambert K, Takimoto T, Topham D . T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol. 2010; 85(1):448-55. PMC: 3014175. DOI: 10.1128/JVI.01812-10. View